irhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ecg, monitoring for patients at risk for arrhythmias. we have created a unique platform, zio by irhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
Company profile
Ticker
IRTC
Exchange
Website
CEO
Kevin King
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
IRhythm Technologies Inc
SEC CIK
Corporate docs
Subsidiaries
iRhythm Technologies Limited • iRhythm Singapore PTE. Ltd. • iRhythm Philippines, Inc. ...
IRTC stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
10 Apr 24
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
8-K
Entry into a Material Definitive Agreement
8 Mar 24
8-K
Irhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
5 Mar 24
8-K
Irhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
4 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Full Year 2023 Financial Results
22 Feb 24
8-K
Entry into a Material Definitive Agreement
8 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
15 Nov 23
Transcripts
IRTC
Earnings call transcript
2023 Q3
2 Nov 23
IRTC
Earnings call transcript
2023 Q2
3 Aug 23
IRTC
Earnings call transcript
2023 Q1
4 May 23
IRTC
Earnings call transcript
2022 Q4
23 Feb 23
IRTC
Earnings call transcript
2022 Q3
2 Nov 22
IRTC
Earnings call transcript
2022 Q2
6 Aug 22
IRTC
Earnings call transcript
2022 Q1
7 May 22
IRTC
Earnings call transcript
2021 Q4
24 Feb 22
IRTC
Earnings call transcript
2021 Q3
6 Nov 21
IRTC
Earnings call transcript
2021 Q3
4 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 47.48 mm | 47.48 mm | 47.48 mm | 47.48 mm | 47.48 mm | 47.48 mm |
Cash burn (monthly) | 4.70 mm | 1.98 mm | 9.20 mm | 8.89 mm | (no burn) | 1.80 mm |
Cash used (since last report) | 32.04 mm | 13.49 mm | 62.73 mm | 60.61 mm | n/a | 12.24 mm |
Cash remaining | 15.44 mm | 33.99 mm | -15.25 mm | -13.13 mm | n/a | 35.23 mm |
Runway (months of cash) | 3.3 | 17.2 | -1.7 | -1.5 | n/a | 19.6 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 221 |
Opened positions | 39 |
Closed positions | 18 |
Increased positions | 76 |
Reduced positions | 72 |
13F shares | Current |
---|---|
Total value | 3.03 tn |
Total shares | 32.56 mm |
Total puts | 290.60 k |
Total calls | 386.90 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 2.96 mm | $278.80 bn |
Capital Research Global Investors | 2.37 mm | $223.77 bn |
Sands Capital Management | 2.35 mm | $221.48 bn |
BLK Blackrock | 2.33 mm | $219.84 bn |
Artisan Partners Limited Partnership | 1.96 mm | $185.00 bn |
Alliancebernstein | 1.38 mm | $129.69 bn |
MKFCF Mackenzie Financial | 1.26 mm | $111.43 bn |
JPM JPMorgan Chase & Co. | 1.23 mm | $116.18 bn |
Blair William & Co | 1.11 mm | $104.76 bn |
Slate Path Capital | 868.70 k | $81.88 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Mar 24 | Sumi Shrishrimal | Common Stock | Sell | Dispose S | No | No | 111.14 | 723 | 80.35 k | 24,429 |
4 Mar 24 | Daniel G. Wilson | Common Stock | Sell | Dispose S | No | No | 111.14 | 2,452 | 272.52 k | 30,515 |
4 Mar 24 | Chad Patterson | Common Stock | Sell | Dispose S | No | No | 111.14 | 1,077 | 119.70 k | 39,865 |
4 Mar 24 | Blackford Quentin S. | Common Stock | Sell | Dispose S | No | No | 111.14 | 4,221 | 469.12 k | 175,794 |
4 Mar 24 | Mark J. Day | Common Stock | Sell | Dispose S | No | No | 111.14 | 3,248 | 360.98 k | 61,164 |
News
iRhythm Prices Upsized Offering Of $575M Of 1.50% Convertible Senior Notes Due 2029
5 Mar 24
10 Health Care Stocks Whale Activity In Today's Session
4 Mar 24
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
4 Mar 24
iRhythm Collaborates With Epic To Streamline Access To Zio Service And Drive More Seamless Connectivity Between Clinicians And Patients
29 Feb 24
Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $133
23 Feb 24
Press releases
Investigation Alert Amylyx, Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson Fistel, LLP
15 Apr 24
iRhythm Technologies, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 8, 2024 deadline
8 Apr 24
IRTC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC
8 Apr 24
DEADLINE ALERT for NYCB, IRTC, and HUT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
8 Apr 24
IRTC DEADLINE TODAY: ROSEN, A RANKED AND LEADING FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC
8 Apr 24